Hypertension, proteinuria, and progression of autosomal dominant polycystic kidney disease: Where do we go from here?

American Journal of Kidney Diseases

Volumn 35, Issue 3, 2000, Pages 547-550

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CITRIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PACLITAXEL; RENIN; TRIACYLGLYCEROL; VASODILATOR AGENT;

CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROGNOSIS; PROTEINURIA;

EID: 0034001956     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(00)70213-7     Document Type: Editorial

References (34)

1. W Braasch Clinical data of polycystic kidney Surgery 23 1916 697 702
2. F Schacht Hypertension and vascular studies in congenital polycystic kidney. Mayo Foundation Thesis for Master of Science in Urology 1930 University of Minnesota St Paul, MN 1 53
3. F Schacht Hypertension in cases of congenital polycystic kidney Arch Intern Med 47 1931 500 509
4. C Iglesias V Torres K Offord K Holley C Beard L Kurland Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980 Am J Kidney Dis 2 1983 630 639
5. M Zeier P Fehrenbach S Geberth K Mohring R Waldherr E Ritz Renal histology in polycystic kidney disease with incipient and advanced renal failure Kidney Int 42 1992 1259 1265
6. A Chapman A Johnson P Gabow R Schrier Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease J Am Soc Nephrol 5 1994 1349 1354
7. S Klahr J Breyer G Beck V Dennis J Hartman D Roth T Steinman S Wang M Yamamoto Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease J Am Soc Nephrol 5 1995 2037 2047
8. E Lewis L Hunsicker R Bain R Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
9. S Klahr A Levey G Beck A Caggiula L Hunsicker J Kusek G Striker The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease N Engl J Med 330 1994 877 884
10. G Maschio D Alberti G Janin F Locatelli J Mann M Motolese C Ponticelli E Ritz P Zucchelli Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
11. G Remuzzi G Tognoni Randomised placebo-controlled trial of effect of ramipril on decine in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Lancet 349 1997 1857 1863
12. R Toto H Mitchell R Smith H-C Lee D McIntire W Pettinger “Strict” blood pressure control and progression of renal disease in hypertensive nephrosclerosis Kidney Int 48 1995 851 859
13. L Ruilope C Campo F Rodriquez-Artalejo V Lahera R Garcia-Robles J Rodicio Blood pressure and renal function: Therapeutic implications J Hypertens 14 1996 1259 1263
14. R Bigazzi S Bianchi D Baldari V Campese Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension J Hypertens 16 1998 1325 1333
15. C Burton K Harris The role of proteinuria in the progression of chronic renal failure Am J Kidney Dis 27 1996 765 775
16. S Sommers J Melamed Renal pathology of essential hypertension Am J Hypertens 3 1990 583 587
17. H-H Parving F Gyntelberg Transcapillary escape rate of albumin and plasma volume in essential hypertension Circ Res 32 1973 643 651
18. H-H Parving C Mogensen H Jensen P-E Evrin Increased urinary albumin-excretion rate in benign essential hypertension Lancet 1 1974 1190 1192
19. C Erley M Holzer B Krämer T Risler Renal haemodynamics and organ damage in young hypertensive patients with different plasma renin activities after ACE inhibition Nephrol Dial Transplant 7 1992 216 220
20. S Bianchi R Bigazzi C Valtriani I Chiapponi G Sgherri G Baldari A Natali E Ferrannini V Campese Elevated serum insulin levels in patients with essential hypertension and microalbuminuria Hypertension 23 1994 681 687
21. R Bigazzi S Bianchi D Baldari G Sgherri G Baldari V Campese Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factors Hypertension 23 1994 195 199
22. A Miyoshi H Suzuki M Fujiwara M Masai T Iwasaki Impairment of endothelial function in salt-sensitive hypertension in humans Am J Hypertens 10 1997 1083 1090
23. P Mattei F Arzilli R Giovannetti G Penno P Arright S Taddei A Salvetti Microalbuminuria and renal-haemodynamics in essential hypertension Eur J Clin Invest 27 1997 755 760
24. V Campese Salt-sensitive hypertension: Renal and cardiovascular implications Nutr Metab Cardiovasc Dis 9 1999 143 156
25. R Bigazzi S Bianchi D Baldari G Sgherri G Baldari V Campese Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension Hypertension 6 1993 108 113
26. J Janssen R Gans J van der Meulen R Pijpers P ter Wee Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: A double-blind, randomized prospective study Am J Hypertens 11 1998 1074 1079
27. L Ruilope J Alcazar E Hernandez M Praga V Lahera J Rodicio Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension Kidney Int 45 suppl 45 1994 S171 S173
28. E Schiffrin Vascular protection with newer antihypertensive agents J Hypertens 16 suppl 1998 S25 S29
29. C Sharp A Johnson P Gabow Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease J Am Soc Nephrol 9 1998 1908 1914
30. A Martinez-Vea C Gutierrez A Bardaji R Pastor C Garcia C Peralta C Richart J Oliver Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease Scand J Urol Nephrol 32 1998 356 359
31. D Wang S Strandgaard The pathogenesis of hypertension in autosomal dominant polycystic kidney disease J Hypertens 15 1997 925 933
32. T Ecder AB Chapman GM Brosnahan CL Edelstein AM Johnson RW Schrier Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease Am J Kidney Dis 35 2000 427 432
33. VE Torres New insights into polycystic kidney disease and its treatment Curr Opin Nephrol Hyperten 7 1998 159 169
34. W Sweeney Jr Y Chen K Nakanishi P Frost E Avner Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor Kidney Int 57 2000 33 40